Market Assessment

The energy sector is a crucial enabler to economic growth in many countries. Consequently, there are a number of private firms, governments and development partners who are heavily investing huge amounts of money on energy projects. Due to the nature of these projects, few foreign firms have the requisite resources and technical capacity to handle mega energy investments. In most cases, local firms lack capacity to undertake the projects. Additionally, as countries exploit resources they have, they are mindful of the gains the local communities would accrue from energy projects in terms of skills and technology transfer, employment and building...

This is a best prospect industry sector for this country. Includes a market overview and trade data.

The Kenya Pharmaceutical Industry Diagnostic Report 2020 highlights and examines gaps, challenges, and opportunities in Kenya’s pharmaceutical industry. The report recommends steps to spur the industry’s growth and make it more competitive

The pharmaceutical landscape in Kenya constitutes a number of multinational companies that are present through locally incorporated affiliates, technical representative offices and local technical agents. The presence of these companies has made the industry more competitive, with an emphasis on maintaining both quality and affordability. Asoko has mapped the leading 25 players working across manufacturing, distribution and retail of pharmaceuticals and medical equipment. The industry is dominated by private companies, with 14 of the leading players being private companies. Among the rest, seven are multinationals and four are family owned.

Access to affordable, safe, effective, and quality-assured medicines by a patient is important for good health outcomes. Unfortunately, there is sparse literature published on the pharmaceutical enablers that may increase the sale of a substandard and falsified (SF) medicine to a patient in Kenya. The review highlights some of the factors that may facilitate the entry of SF medicines into the legitimate pharmaceutical supply chain and discusses their impact on patient access to medicines. Lack of essential medicines in public health facilities is an important factor that may contribute to increased demand for medicine-related out-of-pocket expenses from private health facilities,...